Health Care

Nektar Therapeutics (NASDAQ:NKTR) Takes Off in Trading Today - Up by 18.83%

Nektar Therapeutics (NASDAQ:NKTR) Takes Off in Trading Today - Up by 18.83%”

Mizuho Securities analyst Difei Yang assigned a Buy rating to Nektar Therapeutics (NASDAQ: NKTR) today. American International Group Inc. now owns 118,366 shares of the biopharmaceutical company's stock valued at $2,841,000 after purchasing an additional 6,476 shares during the last quarter. This represents an increase of Infinity compared to the average daily volume of 0 call options.

In other news, CAO Jillian B. Thomsen sold 2,648 shares of the company's stock in a transaction dated Wednesday, August 16th. Ashmore Group Plc sold 21,355 shares as the company's stock rose 11.75% with the market. Following the sale, the chief executive officer now owns 122,908 shares in the company, valued at $1,705,963.04. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. $33,255 worth of stock was sold by Doberstein Stephen K on Tuesday, May 16. The stock was sold at an average price of $13.88, for a total transaction of $1,297,197.04. The company realized a fall in short interest of -1.29% between September 29, 2017 and October 13, 2017.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Bank of New York Mellon Corp boosted its position in shares of Nektar Therapeutics by 0.6% during the second quarter.

Nektar Therapeutics has gapped open sharply higher Monday morning and is now up 8.38 at $40.88 on above average volume. Arizona State Retirement System now owns 80,945 shares of the biopharmaceutical company's stock valued at $1,582,000 after acquiring an additional 800 shares during the last quarter.

Vanguard Gp holds 0.01% in Nektar Therapeutics (NASDAQ:NKTR) or 14.01 million shares. LS Investment Advisors LLC now owns 6,594 shares of the biopharmaceutical company's stock worth $129,000 after purchasing an additional 535 shares during the period. It also increased its holding in Gran Tierra Energy Inc (NYSEMKT:GTE) by 345,800 shares in the quarter, for a total of 2.50M shares, and has risen its stake in Banco Macro Sa (NYSE:BMA). Institutional investors own 95.11% of the company's stock.

Equity Research firms now have a positive stance on shares of Nektar Therapeutics (NASDAQ:NKTR). Nektar Therapeutics has a 52 week low of $11.41 and a 52 week high of $33.67. For the past month, Nektar Therapeutics's stock has been 41.18%, 68.57% for the last quarter, 64.06% for the past six months and 137.57% for the past 52 weeks. The biopharmaceutical company reported ($0.32) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.36) by $0.04. The business had revenue of $36.30 million for the quarter, compared to analysts' expectations of $32.42 million.

"In the dose-escalation stage of the PIVOT trial, we've observed important response rates across all three tumor types - melanoma, renal cell carcinoma and non-small lung cancer - in both PD-L1 positive and PD-L1 negative patients", said Mary Tagliaferri, M.D., Senior Vice President of Clinical Development at Nektar Therapeutics. The firm's revenue for the quarter was up 321.2% on a year-over-year basis. During the same period last year, the firm earned ($0.32) earnings per share. sell-side analysts predict that Nektar Therapeutics will post -0.83 earnings per share for the current year. Finally, Brean Capital reissued a "buy" rating and set a $23.00 price objective on shares of Nektar Therapeutics in a research note on Friday, September 30th. World Asset Management Inc boosted its stake in Nektar Therapeutics by 5.6% in the 2nd quarter. Finally, Canaccord Genuity assumed coverage on shares of Nektar Therapeutics in a report on Thursday. Following the acquisition, the director now directly owns 121,333 shares of the company's stock, valued at $1,637,995.50. Aegis Capital initiated Nektar Therapeutics (NASDAQ:NKTR) on Tuesday, November 8 with "Buy" rating. Nektar Therapeutics has a consensus rating of "Buy" and an average target price of $28.64. Analysts' mean recommendation for the stock is 1.60 (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range).

Among 2 analysts covering IRSA Inversiones (NYSE:IRS), 1 have Buy rating, 0 Sell and 1 Hold. The stock's price is 39.99 and their relative strength index (RSI) stands at 90.97.

WARNING: This story was first posted by Week Herald and is the sole property of of Week Herald. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & worldwide copyright legislation.

Like this


13 November 2017
Mitie Appoints Former Virgin Active CEO Paul Woolf As CFO
Mitie said Woolf, former chief executive of Virgin Active Health Clubs, started his new role on Monday. The company issued a profit warning in May past year and has struggled to get back on course since.

13 November 2017
Pioneer Natural Resources Sees Unusually Large Options Volume (NYSE:PXD)
Guggenheim Ltd Limited Liability Company holds 0.1% of its portfolio in Pioneer Natural Resources (NYSE:PXD) for 243,605 shares. Los Angeles Capital Mngmt Equity Research holds 0% of its portfolio in Pioneer Natural Resources (NYSE:PXD) for 1,295 shares.

13 November 2017
Marvell Technology Group Ltd. (MRVL) Set to Announce Earnings on Wednesday
The stock of Marvell Technology Group Ltd. (NASDAQ: MRVL ) earned "Buy" rating by FBR Capital on Monday, November 6. Great West Life Assurance Can has 0.01% invested in Marvell Technology Group Ltd. (NASDAQ:MRVL) for 223,403 shares.

13 November 2017
Report Says Illinois Is Losing Well-Paid, Blue-Collar Jobs
Highly desirable skilled-industry positions are increasingly being given to workers with associate's degrees. In California, 47 percent of the good-paying jobs for workers without a bachelor's are in blue-collar work.

13 November 2017
'Daredevil' Season 3 Updates: Series to Begin Filming Today
It looks like Daredevil Season 3 will be going in front of cameras very soon as it looks to meet its 2018 release. Netflix's flagship Marvel series, Daredevil , starts filming season 3 in New York City this week.

13 November 2017
Sonakshi Sinha's Ittefaq earns Rs. 27 crore at BO
One of the promotional posters of the film, shows Akshaye Khanna lighting up a cigarette, with no warning placed on it. The murder mystery drama has received a positive response from the audience as well as the critics.

13 November 2017
Lam Research Corporation (LRCX) Shares Bought by Alps Advisors Inc
KeyBanc Capital Markets maintained Lam Research Corporation (NASDAQ:LRCX) on Wednesday, October 18 with "Buy" rating. (NYSE:HES). It worsened, as 43 investors sold LRCX shares while 255 reduced holdings. 110 funds opened positions while 182 raised stakes.

13 November 2017
Apple Inc. (NASDAQ:AAPL) Stake Lowered by Exchange Capital Management Inc
Seven analysts have rated the stock with a hold rating and forty-six have issued a buy rating to the stock. (NASDAQ: AAPL ). The company has a market capitalization of $893,830.00, a P/E ratio of 18.99, a PEG ratio of 1.40 and a beta of 1.25.

13 November 2017
Let children dress up as boys or girls, CofE tells schools
What a four-year-old might try on when they dress up may be rather different from what they would wear as a teenager. The Church educates one million pupils in almost 5,000 schools.

13 November 2017
Shark hits surfer on NSW Central Coast
A BRIT doctor has told how he punched a "great white shark" that tried to rip his arm off during a surfing holiday in Australia. Avoca Beach and North Avoca have been closed for 24 hours.